A recent study by Moral et al. supports this further by showing the ILC2s in pancreatic ductal adenocarcinoma (PDAC) cells are highly receptive to PD-1 blockade and augment tissue-specific tumour immunity [68]. This evidence concerns the gene PDCD1 and neoplasm.